$0.4911
0.008001.66%
At close: -
$0.4921
0.001000.20%
After Hours: 7:59 PM EDT
Comments
Loading...
Sangamo Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SGMO | Benzinga
Sangamo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-0.100
Quarterly Revenue Estimate
$29.90M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$63.76M
Analyze the earnings history of Sangamo Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics | -$0.18 | -$0.10 | — | — | $356.00K | $29.90M | — | — | 08/05/2025 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.27 | -$0.13 | -$0.14 | -7.69% | $481.00K | $7.42M | $6.44M | -13.25% | 05/12/2025 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.34 | -$0.09 | -$0.11 | -22.22% | $2.04M | $15.90M | $7.55M | -52.51% | 03/17/2025 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.59 | -$0.03 | $0.04 | 233.33% | $9.40M | $17.94M | $49.41M | 175.43% | 11/12/2024 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.37 | -$0.15 | -$0.18 | -20.00% | $6.83M | $8.26M | $356.00K | -95.69% | 08/06/2024 | Get Alert |
| SGMO | Sangamo Therapeutics | $0.12 | -$0.21 | -$0.27 | -28.57% | $157.96M | $6.65M | $481.00K | -92.77% | 05/09/2024 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.32 | -$0.26 | -$0.34 | -30.77% | $27.23M | $8.10M | $2.04M | -74.79% | 03/13/2024 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.34 | -$0.32 | -$0.59 | -84.38% | $26.46M | $10.40M | $9.40M | -9.63% | 11/01/2023 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.29 | -$0.34 | -$0.37 | -8.82% | $29.38M | $14.83M | $6.83M | -53.91% | 08/08/2023 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.30 | -$0.33 | $0.12 | 136.36% | $28.23M | $24.06M | $157.96M | 556.51% | 04/26/2023 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.26 | -$0.36 | -$0.32 | 11.11% | $27.99M | $26.86M | $27.23M | 1.38% | 02/22/2023 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.33 | -$0.35 | -$0.34 | 2.86% | $28.56M | $26.59M | $26.46M | -0.49% | 11/03/2022 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.33 | -$0.35 | -$0.29 | 17.14% | $27.87M | $24.63M | $29.38M | 19.28% | 08/04/2022 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.32 | -$0.31 | -$0.30 | 3.23% | $26.28M | $27.29M | $28.23M | 3.45% | 05/05/2022 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.29 | -$0.34 | -$0.26 | 23.53% | $25.80M | $26.82M | $27.99M | 4.35% | 02/24/2022 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.01 | -$0.34 | -$0.33 | 2.94% | $57.76M | $25.19M | $28.56M | 13.39% | 11/04/2021 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.26 | -$0.31 | -$0.33 | -6.45% | $21.55M | $26.48M | $27.87M | 5.26% | 08/05/2021 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.37 | -$0.30 | -$0.32 | -6.67% | $13.08M | $23.98M | $26.28M | 9.59% | 05/04/2021 | Get Alert |
| SGMO | Sangamo Therapeutics | $0.04 | -$0.21 | -$0.29 | -38.10% | $54.85M | $32.15M | $25.80M | -19.75% | 02/24/2021 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.24 | — | -$0.01 | — | $21.96M | — | $57.76M | — | 11/04/2020 | Get Alert |
| SGMO | Sangamo Therapeutics | -$0.26 | — | -$0.26 | — | $17.55M | — | $21.55M | — | 08/05/2020 | Get Alert |
Sangamo Therapeutics (SGMO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-0.14 | $-0.13 | -7.69 % |
| Q4 | 2025-03-17 | $-0.11 | $-0.09 | -22.2 % |
| Q3 | 2024-11-12 | $0.04 | $-0.03 | 233.3 % |
| Q2 | 2024-08-06 | $-0.18 | $-0.15 | -20.0 % |
Sangamo Therapeutics (SGMO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $6.44M | $7.42M | -13.3 % |
| Q4 | 2025-03-17 | $7.55M | $15.90M | -52.5 % |
| Q3 | 2024-11-12 | $49.41M | $17.94M | 175.4 % |
| Q2 | 2024-08-06 | $356.00K | $8.26M | -95.7 % |
FAQ
When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?
Sangamo Therapeutics (SGMO) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Sangamo Therapeutics (NASDAQ:SGMO)?
The Actual EPS was $-0.14, which missed the estimate of $-0.13.
What were Sangamo Therapeutics’s (NASDAQ:SGMO) revenues?
The Actual Revenue was $6.4M, which missed the estimate of $7.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
